The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy

Marine Drugs

Volumn 12, Issue 6, 2014, Pages 3292-3306

  Wang, Jing ^a,c   Liu, Huaide ^b   Li, Ning ^a   Zhang, Quanbin ^a,c   Zhang, Hong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b NANTONG UNIVERSITY   (China)

^c Materials and Textiles of Shandong Province ^*  (China)

Author keywords

Diabetic nephropathy; Fucoidan; Sulfated polysaccharide

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CREATININE; FUCOIDIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; MICROALBUMIN; NITROGEN; STREPTOZOCIN; UNCLASSIFIED DRUG; UREA; GLUCOSE BLOOD LEVEL; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; MALE; MORPHOMETRICS; NONHUMAN; PHYSICAL ACTIVITY; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; WISTAR RAT; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE COURSE; DRUG EFFECTS; METABOLISM;

ANIMALS; BETA 2-MICROGLOBULIN; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; INSULIN; MALE; POLYSACCHARIDES; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84903535066     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12063292     Document Type: Article

References (41)

1. Ritz, E.; Rychlík, I.; Locatelli, F.; Halimi, S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am. J. Kidney Dis. 1999, 34, 795-808. (Pubitemid 29521694)
2. Chuang, L.Y.; Guh, J.Y. Extracellular signals and intracellular pathways in diabetic nephropathy. Nephrology 2001, 6, 165-172.
3. Kanter, M. Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J. Mol. Histol. 2009, 40, 107-115.
4. Ihm, C.-G.; Lee, G.S.; Nast, C.C.; Artishevsky, A.; Guillermo, R.; Levin, P.S.; Glassock, R.J.; Adler, S.G. Early increased renal procollagen α1 (IV) mRNA levels in streptozotocin induced diabetes. Kidney Int. 1992, 41, 768-777.
5. Brenner, B.M.; Cooper, M.E.; de Zeeuw, D.; Keane, W.F.; Mitch, W.E.; Parving, H.H.; Remuzzi, G.; Snapinn, S.M.; Zhang, Z.; Shahinfar, S.; et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001, 345, 861-869.
6. Zhang, J.Q.; Xie, X.; Li, C.; Fu, P. Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J. Ethnopharmacol. 2009, 126, 189-196.
7. Li, S.P.; Zhang, G.H.; Zeng, Q.; Huang, Z.G.; Wang, Y.T.; Dong, T.T.; Tsim, K.W. Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine 2006, 13, 428-433. (Pubitemid 43728732)
8. He, C.Y.; Li, W.D.; Guo, S.X.; Lin, S.Q.; Lin, Z.B. Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. J. Asian Nat. Prod. Res. 2006, 8, 705-711.
9. Zhang, Y.W.; Wu, C.Y.; Cheng, J.T. Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-κB and IκB in renal cortex of streptozotoxin-induced diabetic rats. J. Ethnopharmacol. 2007, 114, 387-392.
10. Witvrouw, M.; de Clercq, E. Sulfated Polysaccharides Extracted from Sea Algae as Potential Antiviral Drugs. Gen. Pharmacol. 1997, 29, 497-511.
11. Baba, M.; de Clercq, E.; Schols, D.; Pauwels, R.; Snoeck, R.; van Boeckel, C.; van Dedem, G.; Kraaijeveld, N.; Hobbelen, P.; Ottenheijm, H.; et al. Novel sulfated polysaccharides: Dissociation of anti-human immunodeficiency virus activity from antithrombin activity. J. Infect. Dis. 1990, 161, 208-213.
12. Bilan, M.I.; Usov, A.I. Structural Analysis of Fucoidans. Nat. Prod. Commun. 2008, 3, 1639-1648.
13. Feldman, S.C.; Reynaldi, S.; Stortz, C.A.; Cerezo, A.S.; Damont, E.B. Antiviral properties of fucoidan fractions from Leathesia difformis. Phytomedicine 1999, 6, 335-340.
14. Jia, Y.H. Laminaria japonica Aresch in Chinese Pharmaceutics of Maine Lakes and Marshes; Xueyuan Press: Beijing, China, 1996; pp. 321-322.
15. Wang, J.; Zhang, Q.; Jin, W.; Niu, X.; Zhang, H. Effects and mechanism of low molecular weight fucoidan in mitigating the peroxidative and renal damage induced by adenine. Carbohydr. Polym. 2011, 84, 417-423.
16. Wang, J.; Wang, F.; Yun, H.; Zhang, H.; Zhang, Q. Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease. J. Ethnopharmacol. 2012, 139, 807-813.
17. Zhang, Q.B.; Li, Z.; Xu, Z.; Niu, X.; Zhang, H. Effects of fucoidan on chronic renal failure in rats. Planta Med.2003, 69, 537-541. (Pubitemid 36870629)
18. Zhang, Q.B.; Li, N.; Zhao, T.; Qi, H.; Xu, Z.; Li, Z. Fucoidan inhibits the development of proteinuria in active Heymann nephritis. Phytother. Res. 2005, 19, 50-53. (Pubitemid 40444994)
19. Wang, J.; Jin, W.; Zhang, W.; Hou, Y.; Zhang, H.; Zhang, Q. Hypoglycemic property of acidic polysaccharide extracted from Saccharina japonica and its potential mechanism. Carbohydr. Polym. 2013, 95, 143-147.
20. Yang, W.; Yu, X.; Zhang, Q.; Lu, Q.; Wang, J.; Cui, W.; Zheng, Y.; Wang, X.; Luo, D. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Exp. Eye Res. 2013, 115, 96-105.
21. Cui, W.; Zheng, Y.; Zhang, Q.; Wang, J.; Wang, L.; Yang, W.; Guo, C.; Gao, W.; Wang, X.; Luo, D. Low-molecular-weight fucoidan protects endothelial function and ameliorates basal hypertension in diabetic Goto-Kakizaki rats. Lab. Invest. 2014, 94, 382-393.
22. Kashihara, N.; Watanabe, Y.; Makino, H.; Wallner, E.I.; Kanwar, Y.S. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc. Natl. Acad. Sci. USA 1992, 89, 6309-6313.
23. Ha, H.; Kim, C.; Son, Y.; Chung, M.H.; Kim, K.H. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Rad. Biol. Med. 1994, 16, 271-274. (Pubitemid 24117509)
24. Brezniceanu, M.; Liu, F.; Wei, C.C.; Tran, S.; Sachetelli, S.; Zhang, S.L.; Guo, D.F.; Filep, J.G.; Ingelfinger, J.R.; Chan, J.S. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. 2007, 71, 912-923. (Pubitemid 46663797)
25. Ha, H.; Hwang, I.A.; Park, J.H.; Lee, H.B. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res. Clin. Pract. 2008, 82, S42-S45.
26. Bhatia, S.; Shukla, R.; Venkata Madhu, S.; Kaur Gambhir, J.; Madhava Prabhu, K. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin. Biochem. 2003, 36, 557-562.
27. Wang, J.; Zhang, Q.; Zhang, Z.; Li, Z. Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica. Int. J. Biol. Macromol. 2008, 42, 127-132.
28. Suzuki, R.; Okada, Y.; Okuyama, T. The favorable effect of style of Zea mays L. on streptozotocin induced diabetic nephropathy. Biol. Pharm. Bull. 2005, 28, 919-920. (Pubitemid 40740669)
29. Guerrero-Analco, J.A.; Hersch-Martínez, P.; Pedraza-Chaverri, J.; Navarrete, A.; Mata, R. Antihyperglycemic effect of constituents from Hintonia standleyana in streptozotocin-induced diabetic rats. Planta Med. 2005, 71, 1099-1105. (Pubitemid 43107054)
30. Xu, J.; Li, Z.; Cao, M.; Zhang, H.; Sun, J.; Zhao, J.; Zhou, Q.; Wu, Z.; Yang, L. Synergetic effect of Andrographis paniculata polysaccharide on diabetic nephropathy with andrographolide. Int. J. Biol. Macromol. 2012, 51, 738-742.
31. Cohen, M.P.; Clements, R.S.; Cohen, J.A.; Shearman, C.W. Prevention of decline in renal function in the diabetic db/db mouse. Diabetologia 1996, 39, 270-274. (Pubitemid 26066799)
32. Montilla, P.; Barcos, M.; Munoz, M.C.; Bujalance, I.; Munoz-Castaneda, J.R.; Tunez, I. Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J. Biochem. Mol. Biol. 2005, 38, 539-544. (Pubitemid 43240987)
33. Clark, T.A.; Heyliger, C.E.; Edel, A.L.; Goel, D.P.; Pierce, G.N. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats. Metabolism 2004, 53, 1145-1151. (Pubitemid 39140749)
34. Larkins, R.G.; Dunlop, M.E. The link between hyperglycemia and diabetic nephropathy. Diabetologia 1992, 35, 499-504.
35. Zhao, R.; Li, Q.W.; Li, J.; Zhang, T. Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats. Can. J. Physiol. Pharmacol. 2009, 87, 711-719.
36. Gil, N.; Goldberg, R.; Neuman, T.; Garsen, M.; Zcharia, E.; Rubinstein, A.M.; van Kuppevelt, T.; Meirovitz, A.; Pisano, C.; Li, J.P.; et al. Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes 2012, 61, 208-216.
37. Dubois, M.; Gilles, K.A.; Hamilton, J.K.; Rebers, P.A.; Smith, F. Colorimetric Method for Determination of Sugars and Related Substabces . Anal. Chem. 1956, 28, 350-357.
38. Kawai, Y.; Seno, N.; Anno, K. A modified method for chondrosulfatase assay. Anal. Biochem. 1969, 32, 314-321.
39. Bitter, T.; Muir, H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 1962, 4, 330-334.
40. Honda, S.; Akao, E.; Suzuki, S.; Okuda, M.; Kakehi, K.; Nakamura, J. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl5- pyrazolone derivatives. Anal. Biochem. 1989, 180, 351-357. (Pubitemid 19198072)
41. Barham, D.; Trinder, P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972, 97, 142-145.